| 000 | 01473 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250516174829.0 | ||
| 264 | 0 | _c20140512 | |
| 008 | 201405s 0 0 eng d | ||
| 022 | _a1558-822X | ||
| 024 | 7 |
_a10.1007/s11899-013-0182-1 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBartalucci, Niccolò | |
| 245 | 0 | 0 |
_aPreclinical models for drug selection in myeloproliferative neoplasms. _h[electronic resource] |
| 260 |
_bCurrent hematologic malignancy reports _cDec 2013 |
||
| 300 |
_a317-24 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aDrug Evaluation, Preclinical |
| 650 | 0 | 4 |
_aGATA1 Transcription Factor _xphysiology |
| 650 | 0 | 4 | _aGene Knock-In Techniques |
| 650 | 0 | 4 |
_aHematologic Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aJanus Kinase 2 _xantagonists & inhibitors |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Transgenic |
| 650 | 0 | 4 |
_aMolecular Targeted Therapy _xmethods |
| 650 | 0 | 4 |
_aMyeloproliferative Disorders _xdrug therapy |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xtherapeutic use |
| 700 | 1 | _aBogani, Costanza | |
| 700 | 1 | _aVannucchi, Alessandro M | |
| 773 | 0 |
_tCurrent hematologic malignancy reports _gvol. 8 _gno. 4 _gp. 317-24 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s11899-013-0182-1 _zAvailable from publisher's website |
| 999 |
_c23190199 _d23190199 |
||